Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Urine Test Shows Promise for Early Detection of Bladder Cancer
1
Mins
June 2024
EarlyTect BCD, a new urine-based test, shows high clinical performance in detecting bladder cancer among haematuria patients.
Read more
1
Mins
28th January 2022
Experts Concerned by the Rise in Young-Onset Cancers
Evidence revealed by researchers at Flinders University and UCLA has demonstrated a rise in gastrointestinal cancers in those under 50…
2
Mins
8th November 2021
Amivantamab Successfully Prolongs Survival in Rare Lung Cancer Mutation
Amivantamab has the potential to address the high unmet need in the treatment of people with EGFR exon 20 insertion mutations in non-small cell lung cancer
1
Mins
22nd October 2021
Two Subtypes of Metastatic Prostate Cancer Identified
Scientists have identified two subtypes of metastatic prostate cancer that responding differently to treatment.
1
Mins
22nd October 2021
Physical Activity Shows Evidence of Cancer Prevention in the USA
Engaging in 5 hours per week of moderate-intensity exercise could prevent 46,000 cancer cases annually in the USA.
1
Mins
26th July 2021
COVID-19 Immunity Delayed in Cancer Patients
Recent evidence has shown that cancer patients lack seropositivity following a single dose of the Pfizer-BioNTech mRNA COVID-19 vaccine. This urges the need for patients undergoing cancer treatment to be prioritised in the vaccine scheme, as their protection against the virus is delayed, relative to a healthy population.
1
Mins
26th July 2021
Moderate Alcohol Consumption Linked to Higher Risk of Cancer Development
SURPRISING new evidence has emerged suggesting a strong link between alcohol consumption and an increased risk of developing certain cancers.
1
Mins
23rd April 2021
What Factors Predict Severe Reactions from Immunotherapy?
PREDICTING which patients with cancer may be at risk of severe side effects from immunotherapy may be improved through the identification of specific risk..
1
Mins
23rd April 2021
Safety Tests Passed for Personalised Cancer Vaccine
VACCINE therapies for cancers have been a focus for developments in personalised medicine, and a recent Phase I trial has shown promising results…
Loading posts...
« Previous
1
…
6
7
8
9
10
…
32
Next »